BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 16, 2002
View Archived Issues
Sprinkle administration approved for ADHD treatment
Read More
Vioxx labeling changes and new indication
Read More
Phase IIA trial of oral AOD-9604 scheduled to begin next month
Read More
Preclinical development of PRE-703 for anxiety expected to be completed this year
Read More
Hedgehog antagonist with potential in BCC identified at Curis using novel screening assays
Read More
Over 95% of prostate cancer patients express target of Provenge vaccine
Read More
Squalamine effective in breast cancer model alone and in combination with Herceptin
Read More
Potential of Erbitux as combination therapy in colorectal carcinoma
Read More
AACR news: Javelin-based vaccine safe and immunogenic in melanoma patients
Read More
Spotlight on neuroprotective agents discussed at the AAN meeting
Read More
The use of statins in neurological complications
Read More
SSADH deficiency, a potentially treatable neurometabolic disease
Read More
American Psychiatric Association issues new guidelines on bipolar disorder treatment
Read More
AVP antagonists, their SAR and biological activity described by R.W. Johnson at ACS meeting
Read More
Protopic launched in Germany for atopic dermatitis
Read More
Roche adds MV-026048 to HIV portfolio
Read More
Product R to enter phase II as topical treatment for genital warts
Read More
Committee recommends approval of Cozaar to delay renal disease in type 2 diabetics
Read More
AMD-3100 evaluated in healthy volunteers in combination with Neupogen
Read More
Merckle and Forest reach agreement over ML-3000 in U.S.
Read More
Dose-titration study of Symlin initiated in response to FDA approvable letter
Read More
Basilea patents new antibacterial erythromycin analogues
Read More
New compounds from Merck possess 5-HT1A receptor-agonist and D2 receptor-antagonist effects
Read More
SSRIs discovered at Pfizer claimed specifically for premature ejaculation
Read More
Anticoagulants acting via inhibition of thrombin designed at AstraZeneca
Read More
Synthesis and use of factor Xa inhibitors described in patent by Lilly
Read More
Selective PPARdelta activators and their use
Read More
Indole derivatives bind to D4 receptors and are potentially useful for Rx of CNS disorders
Read More
